Charles River Laboratories · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← CRL

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-27	1.00	−2.7%	—	0.12	-0.00	-0.1%	0.18	-0.03	0.12	—
FY2026 Q1	2026-03-28	1.00	+1.2%	—	0.12	-0.01	-1.5%	0.04	-0.30	0.21	—
FY2025 Q4	2025-12-27	0.99	−0.8%	—	-0.28	-0.28	-27.8%	0.15	-5.57	0.00	—
FY2025 Q3	2025-09-27	1.00	−0.5%	—	0.13	0.05	5.4%	0.21	1.10	0.00	—
FY2025 Q2	2025-06-28	1.03	+0.6%	—	0.10	0.05	5.1%	0.20	1.06	0.01	—
FY2025 Q1	2025-03-29	0.98	−2.7%	—	0.07	0.03	2.6%	0.17	0.50	0.35	—
FY2024 Q4	2024-12-28	1.00	−1.1%	—	-0.17	-0.21	-21.4%	0.16	-4.17	0.00	—
FY2024 Q3	2024-09-28	1.01	−1.6%	34.6%	0.12	0.07	6.9%	0.25	1.33	0.10	—
FY2024 Q2	2024-06-29	1.03	−3.2%	34.5%	0.15	0.09	9.2%	0.19	1.74	0.01	—
FY2024 Q1	2024-03-30	1.01	−1.7%	34.1%	0.13	0.07	7.2%	0.13	1.30	0.01	—
FY2023 Q4	2023-12-30	1.01	−7.9%	—	0.13	0.19	18.5%	0.22	3.63	0.00	—
FY2023 Q3	2023-09-30	1.03	+3.8%	35.2%	0.15	0.09	8.5%	0.21	1.69	0.00	—
FY2023 Q2	2023-07-01	1.06	—	37.6%	0.16	0.10	9.2%	0.15	1.89	0.00	—
FY2023 Q1	2023-04-01	1.03	—	36.7%	0.17	0.10	10.0%	0.11	2.01	0.02	—
FY2022 Q4	2022-12-31	1.10	—	—	0.16	0.19	17.0%	0.23	3.66	0.00	—
FY2022 Q3	2022-09-24	0.99	—	—	0.15	0.10	9.8%	0.13	1.88	0.00	—

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.